Sven Rottenberg#


Sven Rottenberg
Membership Number:7485
Membership type:ORDINARY
Section:BIOCHEMISTRY & MOLECULAR BIOLOGY
Elected:2026
Main Country of Residence:SWITZERLAND
Homepage(s):https://www.itpa.vetsuisse.unibe.ch/research/therapy_escape_of_cancer/index_eng.html
ORCID:0000-0003-2044-9844
Publication Link:





Present and Previous Positions
  • 2014 - present Director of the Institute of Animal Pathology, Vetsuisse, University of Bern
  • 2012 - 2014 Group leader (assoc. professor), The Netherlands Cancer Institute (NKI), Amsterdam
  • 2010 - 2012 Associate staff scientist, Molecular Biology, NKI, Amsterdam
  • 2007 - 2010 Senior postdoctoral fellow, Molecular Biology, NKI, Amsterdam
  • 2004 - 2007 Postdoctoral fellow, Molecular Biology, NKI, Amsterdam
  • 1999 - 2004 Combined residency/PhD program, Institute of Animal Pathology, University of Bern
  • 1998 - 1999 Resident in Domestic Animal Sciences, University of Kiel, Germany

Fields of Scholarship
  • Volume-regulated Anion Channel
  • PARP Inhibitors
  • Theileria-induced host cell transformation
  • Animal pathology
  • Mammary tumoroids
  • Genetically engineered mouse models
  • BRCA1/2
  • DNA repair
  • Loss-of-function genetic screens
  • Mechanisms of anti-cancer therapy resistance

Honours and Awards
  • 2023 TANDEM Award of the ISREC Foundation together with I. Labidi-Galy (CHF 550,000)
  • 2023 Award of the Basser Center for BRCA (USD 100,000)
  • 2022 Membership, European Academy of Cancer Sciences
  • 2021 European Research Council (ERC) Advanced grant (883877): Targeting the essentialome of radiotherapy-resistant cancer (TETHER); EUR 2,500,000
  • 2021 Membership, Swiss Academy of Medical Sciences
  • 2019 Pilot Project Award, Bern Center for Precision Medicine, Switzerland (CHF 54,000)
  • 2016 European Research Council (ERC) consolidator grant (681572): Synthetic viability of homologous recombination-deficient cancers (SYNVIA); EUR 2,000,000
  • 2011 VIDI Award of the Netherlands Organization for Scientific Research to study mechanism of chemotherapy resistance (EUR 800,000)
  • 2010 American Assoc. for Cancer Research (AACR) – Translational Cancer Medicine Award
  • 2004, 2005 Postdoctoral Fellowships by the Swiss National Science Foundation and Swiss Society of Medical-Biological Sciences (PBBEB-104429, PASM33-108943)
  • 2003 Young Investigator Award, American Society of Veterinary Pathologists (ASVP)
  • 2003 Swiss Society of Tropical Medicine and Parasitology Award 2003


Imprint Privacy policy « This page (revision-7) was last changed on Friday, 24. April 2026, 07:46 by Kaiser Dana
  • operated by